chr21-32641973-C-A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_203446.3(SYNJ1):​c.3518-7G>T variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.284 in 1,613,026 control chromosomes in the GnomAD database, including 65,816 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.28 ( 6113 hom., cov: 31)
Exomes 𝑓: 0.28 ( 59703 hom. )

Consequence

SYNJ1
NM_203446.3 splice_region, intron

Scores

2
Splicing: ADA: 0.00008293
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: -0.623

Publications

14 publications found
Variant links:
Genes affected
SYNJ1 (HGNC:11503): (synaptojanin 1) This gene encodes a phosphoinositide phosphatase that regulates levels of membrane phosphatidylinositol-4,5-bisphosphate. As such, expression of this enzyme may affect synaptic transmission and membrane trafficking. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2011]
SYNJ1 Gene-Disease associations (from GenCC):
  • genetic developmental and epileptic encephalopathy
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • developmental and epileptic encephalopathy, 53
    Inheritance: AR Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • early-onset Parkinson disease 20
    Inheritance: AR Classification: STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • undetermined early-onset epileptic encephalopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • atypical juvenile parkinsonism
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • young-onset Parkinson disease
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.65).
BP6
Variant 21-32641973-C-A is Benign according to our data. Variant chr21-32641973-C-A is described in ClinVar as Benign. ClinVar VariationId is 586760.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.332 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SYNJ1NM_203446.3 linkc.3518-7G>T splice_region_variant, intron_variant Intron 28 of 32 ENST00000674351.1 NP_982271.3 O43426-2C9JFZ1Q05CZ1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SYNJ1ENST00000674351.1 linkc.3518-7G>T splice_region_variant, intron_variant Intron 28 of 32 NM_203446.3 ENSP00000501530.1 O43426-2

Frequencies

GnomAD3 genomes
AF:
0.283
AC:
42907
AN:
151788
Hom.:
6106
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.272
Gnomad AMI
AF:
0.245
Gnomad AMR
AF:
0.278
Gnomad ASJ
AF:
0.399
Gnomad EAS
AF:
0.345
Gnomad SAS
AF:
0.314
Gnomad FIN
AF:
0.227
Gnomad MID
AF:
0.375
Gnomad NFE
AF:
0.285
Gnomad OTH
AF:
0.305
GnomAD2 exomes
AF:
0.289
AC:
72536
AN:
250784
AF XY:
0.294
show subpopulations
Gnomad AFR exome
AF:
0.270
Gnomad AMR exome
AF:
0.268
Gnomad ASJ exome
AF:
0.403
Gnomad EAS exome
AF:
0.337
Gnomad FIN exome
AF:
0.226
Gnomad NFE exome
AF:
0.283
Gnomad OTH exome
AF:
0.305
GnomAD4 exome
AF:
0.284
AC:
414806
AN:
1461118
Hom.:
59703
Cov.:
35
AF XY:
0.286
AC XY:
207711
AN XY:
726904
show subpopulations
African (AFR)
AF:
0.269
AC:
8997
AN:
33428
American (AMR)
AF:
0.274
AC:
12262
AN:
44680
Ashkenazi Jewish (ASJ)
AF:
0.405
AC:
10573
AN:
26126
East Asian (EAS)
AF:
0.354
AC:
14058
AN:
39674
South Asian (SAS)
AF:
0.321
AC:
27642
AN:
86210
European-Finnish (FIN)
AF:
0.233
AC:
12431
AN:
53386
Middle Eastern (MID)
AF:
0.345
AC:
1989
AN:
5764
European-Non Finnish (NFE)
AF:
0.278
AC:
308886
AN:
1111486
Other (OTH)
AF:
0.298
AC:
17968
AN:
60364
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.469
Heterozygous variant carriers
0
14683
29366
44048
58731
73414
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10416
20832
31248
41664
52080
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.283
AC:
42932
AN:
151908
Hom.:
6113
Cov.:
31
AF XY:
0.283
AC XY:
20980
AN XY:
74242
show subpopulations
African (AFR)
AF:
0.272
AC:
11254
AN:
41408
American (AMR)
AF:
0.278
AC:
4244
AN:
15262
Ashkenazi Jewish (ASJ)
AF:
0.399
AC:
1382
AN:
3468
East Asian (EAS)
AF:
0.345
AC:
1779
AN:
5150
South Asian (SAS)
AF:
0.313
AC:
1511
AN:
4820
European-Finnish (FIN)
AF:
0.227
AC:
2394
AN:
10530
Middle Eastern (MID)
AF:
0.359
AC:
104
AN:
290
European-Non Finnish (NFE)
AF:
0.285
AC:
19395
AN:
67958
Other (OTH)
AF:
0.306
AC:
646
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1555
3110
4666
6221
7776
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
448
896
1344
1792
2240
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.290
Hom.:
3619
Bravo
AF:
0.287
Asia WGS
AF:
0.299
AC:
1041
AN:
3478
EpiCase
AF:
0.300
EpiControl
AF:
0.300

ClinVar

Significance: Benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Apr 20, 2017
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jul 05, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:2
-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Genome Diagnostics Laboratory, Amsterdam University Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Early-onset Parkinson disease 20;C4479313:Developmental and epileptic encephalopathy, 53 Benign:1
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Developmental and epileptic encephalopathy, 53 Benign:1
Jul 15, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Early-onset Parkinson disease 20 Benign:1
Jul 15, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.65
CADD
Benign
5.6
DANN
Benign
0.68
PhyloP100
-0.62
PromoterAI
0.0034
Neutral
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000083
dbscSNV1_RF
Benign
0.0
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2833929; hg19: chr21-34014283; COSMIC: COSV59151924; COSMIC: COSV59151924; API